6 – 10 of 17
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
(
- Contribution to journal › Article
- 2015
-
Mark
Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases
(
- Contribution to journal › Article
-
Mark
Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS - A Novel Therapeutic Opportunity.
(
- Contribution to journal › Article
- 2007
-
Mark
Alpha10 integrin expression is up-regulated on fibroblast growth factor-2-treated mesenchymal stem cells with improved chondrogenic differentiation potential.
(
- Contribution to journal › Article
- 2006
-
Mark
Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma.
(
- Contribution to journal › Article